Pros | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Larger AUM within category. | ![]() Among most bought funds within the category. ![]() Larger AUM within category. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | ![]() 5Y returns in the bottom 25% of the category. |
INDMoney rank | 3/8 | 6/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 7 Years | 12 Years | ||
Fund Size | 5728 Cr | 8569 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 1.06% | 0.89% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 41 | 40 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (12.66%) Dr Reddy's Laboratories Ltd (9.66%) Divi's Laboratories Ltd (9.03%) Cipla Ltd (7.85%) Aurobindo Pharma Ltd (6.34%) | Sun Pharmaceuticals Industries Ltd (12.57%) Divi's Laboratories Ltd (9.49%) Lupin Ltd (5.82%) Cipla Ltd (5.62%) Dr Reddy's Laboratories Ltd (5.49%) | ||
No of Sectors | 3 | 1 | ||
Top 3 Sectors | Health (94.88%) Basic Materials (3.81%) Financial Services (1.31%) | Health (100%) | ||
Equity % | 96.99% | 98.58% | ||
Debt % | - | - | ||
P/E | 31.57 | 37.82 | ||
P/B | 4.13 | 6.01 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 0.99% | 0.28% | ||
3-Month Return | 12.98% | 9.74% | ||
6-Month Return | 3.47% | 1.26% | ||
1-Year Return | 18.56% | 12.81% | ||
3-Year Return | 30.01% | 25.53% | ||
5-Year Return | 25.57% | 23.06% |
Sharpe | 1.43 | 1.26 | ||
Alpha | 3.56 | 1.03 | ||
Beta | 0.94 | 0.9 | ||
Standard Deviation | 15.37 | 14.76 | ||
Information Ratio | 1.04 | -0.25 |
Description | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund - Direct Plan - Growth Plan is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dharmesh Kakkad | Kinjal Desai,Sailesh Raj Bhan |